Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2
Cellular and Molecular Life Sciences · 2025
DOI: 10.1007/s00018-025-05723-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Life Sciences, 2025. Verfasst von Yi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Necroptosis, Neoplastic Stem Cells, Nuclear Pore Complex Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Sailing Program, National Key Clinical Specialty Discipline Construction Program of China.
Abstract (Originalsprache)
Gastric cancer stem cells (GCSCs) play a crucial role in the initiation, progression, recurrence and therapeutic resistance, contributing to a poor prognosis. Consequently, GCSCs are deemed to be a potential therapeutic target for gastric cancer (GC). Although β-catenin is a well-recognized therapeutic target for GC and several inhibitors have demonstrated potent anti-tumor effects, there is a dearth of therapeutic agents targeting β-catenin for clinical therapy. In this study, we carried out high-throughput screening of clinically approved drugs to identify effective inhibitors of β-catenin. The results revealed that the antibiotic drug, clofoctol (CFT) effectively reduced the β-catenin level, attenuated stemness traits both in vitro and in vivo, and induced necroptosis of GCSCs. Further analyzing of downstream genes and targeted proteins, we found that CFT inhibited GCSCs viability by binding to the SUMO E3 ligase RanBP2, thereby suppressing the SerpinE1/β-catenin axis and activating TNF-mediated necroptosis. These results indicate that CFT may exert potent therapeutic effects against GC by targeting β-catenin and inhibiting the viability of GCSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
- Institute of Artificial Intelligence Medicine, Shanghai Academy of Experimental Medicine, Shanghai, China.
- Faculty of Medical Laboratory Science, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China. lisongshen@hotmail.com.
- Institute of Artificial Intelligence Medicine, Shanghai Academy of Experimental Medicine, Shanghai, China. lisongshen@hotmail.com.
- Faculty of Medical Laboratory Science, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. lisongshen@hotmail.com.
Förderung
- National Natural Science Foundation of China
- Shanghai Sailing Program
- National Key Clinical Specialty Discipline Construction Program of China
Zitieren
APA
Liu, Y., Ma, Y., Zhou, B., Bian, B., Zhou, Y., Chen, S., Zhang, P., Shen, L., & Chen, H. (2025). Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-025-05723-8
Vancouver
Liu Y, Ma Y, Zhou B, Bian B, Zhou Y, Chen S, et al. Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2. Cellular and Molecular Life Sciences. 2025. doi:10.1007/s00018-025-05723-8
BibTeX
@article{Liu2025,
author = {Liu, Yi and Ma, Yanhui and Zhou, Bingqian and Bian, Bingxian and Zhou, Yunlan and Chen, Shiyu and Zhang, Peng and Shen, Lisong and Chen, Hui},
title = {Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2},
journal = {Cellular and Molecular Life Sciences},
year = {2025},
doi = {10.1007/s00018-025-05723-8}
}
EUVIMED